Medical News

RSS

OMJPI, Diamyd Medical sign agreement to develop and commercialize GAD65 antigen-based therapy

Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions.

22 Jun 2010

CIGNA, CareCentrix team up to offer Care Transitions Program to decrease hospital readmissions

According to a recent study, one in five hospital discharges is complicated by an adverse event within 30 days, often leading to emergency care or re-hospitalization. To combat this problem, CIGNA (NYSE:CI) and CareCentrix, Inc., have teamed up to offer the Care Transitions Program to people enrolled in a CIGNA health plan after they've been discharged from the hospital. CareCentrix will provide specialized home nursing services that will help these individuals transition from hospital care to home recovery.

22 Jun 2010

Gastric cancer drug market to grow from $700M in 2009 to $1.5B in 2019

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the rapid uptake and market penetration of key targeted agents, beginning with Roche/Genentech/Chugai's Herceptin, will drive the gastric cancer drug market to more than double, from $700 million in 2009 to nearly $1.5 billion in 2019.

22 Jun 2010

Study shows vitamin D deficiency is highly prevalent in patients with Type 2 diabetes

Vitamin D deficiency is highly prevalent in patients with Type 2 diabetes and may be associated with poor blood sugar control, according to a new study. The results will be presented Saturday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

Drunkenness increases risk for violent behaviour in people who suppress anger: Study

A study published today in the journal Addiction reveals that drunkenness increases the risk for violent behaviour, but only for individuals with a strong inclination to suppress anger.

22 Jun 2010

Pfizer to discontinue commercial availability of Mylotarg for AML in U.S.

Pfizer Inc. announced today that based on discussions with the U.S. Food and Drug Administration (FDA), it will be discontinuing commercial availability of Mylotarg® (gemtuzumab ozogamicin for Injection) (used for the treatment of relapsed acute myeloid leukemia (AML)) in the United States and that it will be voluntarily withdrawing the new drug application (NDA) for Mylotarg effective October 15, 2010.

22 Jun 2010

Biotage launches ISOLUTE SLE+ sample preparation columns

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced the introduction of ISOLUTE SLE+ High-Performance Supported Liquid Extraction sample preparation columns. The announcement occurred during the 58th ASMS Conference on Mass Spectrometry and Allied Topics in Salt Lake City, Utah USA.

22 Jun 2010

NTU, Technion announce new collaboration to jointly offer PhD programme

Singapore's leading science and technology university, Nanyang Technological University, and Israel's number one university, Technion-Israel Institute of Technology, today announced a new collaboration to jointly offer a Doctor of Philosophy programme.

22 Jun 2010

FDA Advisory Committee recommendation against flibanserin will not affect LibiGel program: BioSante

BioSante Pharmaceuticals, Inc. commented today that the recommendation on June 18, 2010 by the FDA Advisory Committee regarding the safety and efficacy of flibanserin (Boehringer-Ingelheim) will have no impact on its own ongoing development program or approval pathway for LibiGel (testosterone gel), for the treatment of hypoactive sexual desire disorder (HSDD).

22 Jun 2010

Patients are seeking self-service convenience to manage healthcare expenses: NCR survey

The latest survey of U.S. consumers, commissioned by NCR Corporation, shows that patients are increasingly seeking self-service convenience when managing the financial aspects of their healthcare experience. The annual consumer study, conducted by Buzzback Market Research, reveals that more than half (51 percent) of respondents would like to manage their healthcare account by viewing payment history and settling outstanding balances via online and mobile channels.

22 Jun 2010

KYPHON ActivOs 10 Bone Cement with HA launched to treat patients with VCFs

Medtronic, Inc. today announced the launch of KYPHON ActivOs 10 Bone Cement with Hydroxyapatite, a polymethylmethacrylate bone cement containing hydroxyapatite for use in the treatment of patients with vertebral compression fractures who are undergoing minimally invasive surgery with KYPHON Balloon Kyphoplasty.

22 Jun 2010

New $20M fund to support Haitian small-, medium-sized businesses announced after first Interim Haiti Reconstruction Committee meeting

Former President Bill Clinton along with Mexican telecom executive Carlos Slim and Frank Guistra, a Canadian "mining magnet," on Thursday announced "a $20 million fund to help support the expansion and creation of small- and medium-size Haitian businesses," the Miami Herald reports.

22 Jun 2010

Diamyd Medical, Ortho-McNeil-Janssen Pharmaceuticals sign agreement for diabetes therapy

Diamyd Medical AB has signed an agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), a Johnson & Johnson company, to develop and commercialize the Diamyd® diabetes therapy.

22 Jun 2010

FDA to hold workshop on medical device innovation to address unmet public health needs

Each day, medical devices from renal dialysis machines to implantable defibrillators help prevent, diagnose, treat, and monitor serious and life-threatening diseases. After taking years to develop, these devices then undergo a regulatory review process before entering the marketplace. It then takes even more time for them to be adopted into clinical practice and for patients to realize the benefits.

22 Jun 2010

UC Irvine researchers create "plastic antibodies"

UC Irvine researchers have developed the first "plastic antibodies" successfully employed in live organisms - stopping the spread of bee venom through the bloodstream of mice.

22 Jun 2010

Research article sheds light on liability concerns and electronic health records systems

Electronic health record systems likely will soon become a fixture in medical settings. Advocates claim they will reduce health care costs and improve medical outcomes, which could be critical since the new health care reform law increases access for millions of Americans. Although benefits of bringing information technology to health records can be substantial, EHR systems also give rise to increased liability risks for health care providers due to possible software or hardware problems or user errors.

22 Jun 2010

Report says G8 countries short $10B on $50B commitment, reveals mixed progress on health goals

An accountability report, prepared by officials in G8 member countries' foreign affairs departments, acknowledges that G8 "countries are $10 billion behind the five-year, $50-billion commitment they made at their 2005 summit in Scotland," the Canadian Press/CTV News reports (6/20).

22 Jun 2010

Enobia reports positive interim data from ENB-0040 enzyme replacement therapy study for children with HPP

Enobia Pharma today announced positive interim data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After 12 weeks of treatment with ENB-0040, children with HPP showed marked improvements in bone mineralization and function including increases in strength, endurance and mobility and reduction in pain. These findings were presented by Dr. Michael Whyte at ENDO 2010, the 92nd Annual Meeting of The Endocrine Society.

22 Jun 2010

University of Utah receives $2.4M, four-year grant to track children with ASDs

In the ongoing effort to understand the growing prevalence of autism spectrum disorders nationwide, the University of Utah has received a $2.4 million, four-year grant to estimate the number of Utah 8-year-olds with ASDs and other developmental disabilities.

22 Jun 2010

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.

22 Jun 2010

Medical News

OMJPI, Diamyd Medical sign agreement to develop and commercialize GAD65 antigen-based therapy

CIGNA, CareCentrix team up to offer Care Transitions Program to decrease hospital readmissions

Gastric cancer drug market to grow from $700M in 2009 to $1.5B in 2019

Study shows vitamin D deficiency is highly prevalent in patients with Type 2 diabetes

Drunkenness increases risk for violent behaviour in people who suppress anger: Study

Pfizer to discontinue commercial availability of Mylotarg for AML in U.S.

Biotage launches ISOLUTE SLE+ sample preparation columns

NTU, Technion announce new collaboration to jointly offer PhD programme

FDA Advisory Committee recommendation against flibanserin will not affect LibiGel program: BioSante

Patients are seeking self-service convenience to manage healthcare expenses: NCR survey

KYPHON ActivOs 10 Bone Cement with HA launched to treat patients with VCFs

New $20M fund to support Haitian small-, medium-sized businesses announced after first Interim Haiti Reconstruction Committee meeting

Diamyd Medical, Ortho-McNeil-Janssen Pharmaceuticals sign agreement for diabetes therapy

FDA to hold workshop on medical device innovation to address unmet public health needs

UC Irvine researchers create "plastic antibodies"

Research article sheds light on liability concerns and electronic health records systems

Report says G8 countries short $10B on $50B commitment, reveals mixed progress on health goals

Enobia reports positive interim data from ENB-0040 enzyme replacement therapy study for children with HPP

University of Utah receives $2.4M, four-year grant to track children with ASDs

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News